Medtronic InSync Panel OK May Presage September FDA Approval
This article was originally published in The Gray Sheet
Executive Summary
The Circulatory System Devices Panel's approvable recommendation for Medtronic's InSync pacing system sets the stage for FDA final sign-off by Sept. 30, the last day of the federal fiscal year.